Reuters logo
BRIEF-Tesaro announces European Commission approval of Zejula for women with recurrent ovarian cancer
November 20, 2017 / 12:20 PM / a month ago

BRIEF-Tesaro announces European Commission approval of Zejula for women with recurrent ovarian cancer

Nov 20 (Reuters) - Tesaro Inc

* Tesaro announces European Commission approval of Zejula for women with recurrent ovarian cancer

* Tesaro Inc - ‍approval supported by “robust” data from a randomized phase 3 trial​

* Tesaro Inc - ‍Tesaro plans to launch Zejula in Germany and UK this December, with launches in additional European countries to follow beginning in 2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below